Salek-Ardakani; Shahram

Patent Applications and Registrations

Patent applications and USPTO patent grants for Salek-Ardakani; Shahram.The latest application filed is for "combination therapies using cdk inhibitors".

Company Profile

0.12.9

Salek-Ardakani; Shahram - San Diego CA
Salek-Ardakani; Shahram - La Jolla CA
SALEK-ARDAKANI; SHAHRAM - NEWBERRY FL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination Therapies Using Cdk Inhibitors App 20220241412 - Dann; Stephen George ; et al.	2022-08-04
Combination Therapies Using Cdk Inhibitors App 20220235141 - Dann; Stephen George ; et al.	2022-07-28
Light Inhibitors For Asthma, Lung And Airway Inflammation, Respiratory, Interstitial, Pulmonary And Fibrotic Disease Treatment App 20210179725 - Croft; Michael ; et al.	2021-06-17
Antibodies Specific for CD47, PD-L1, and Uses Thereof App 20210179716 - CHAPARRO RIGGERS; Javier Fernando ; et al.	2021-06-17
Virus vaccination and treatment methods with OX40 agonist compositions Grant 10,106,619 - Croft , et al. October 23, 2	2018-10-23
Methods of treating OX40 mediated recall immune responses using OX40L antibodies and agents useful for identifying same Grant 9,873,744 - Croft , et al. January 23, 2	2018-01-23
Light Inhibitors For Asthma, Lung And Airway Inflammation, Respiratory, Interstitial, Pulmonary And Fibrotic Disease Treatment App 20170058037 - Croft; Michael ; et al.	2017-03-02
Lipoteichoic Acid From Lactobacilli As A Potent Immune Stimulatory Adjuvant For Vaccine Development App 20170035880 - MOHAMADZADEH; MANSOUR ; et al.	2017-02-09
LIGHT inhibitors for asthma, lung and airway inflammation, respiratory, interstitial, pulmonary and fibrotic disease treatment Grant 9,301,994 - Croft , et al. April 5, 2	2016-04-05
Methods of treating OX40 mediated recall immune responses using OX40L antibodies and agents useful for identifying same Grant 8,956,615 - Croft , et al. February 17, 2	2015-02-17
Methods of treating OX40 mediated recall immune responses using OX40L antibodies and agents useful for identifying same Grant 8,551,477 - Croft , et al. October 8, 2	2013-10-08
Virus Vaccination And Treatment Methods With Ox40 Agonist Compositions App 20120141465 - CROFT; MICHAEL ; et al.	2012-06-07
Methods of treating OX40 mediated recall immune responses using OX40L antibodies and agents useful for identifying same Grant 8,101,175 - Croft , et al. January 24, 2	2012-01-24
Light Inhibitors For Asthma, Lung and Airway Inflammation, Respiratory, Interstitial, Pulmonary and Fibrotic Disease Treatment App 20110150785 - Croft; Michael ; et al.	2011-06-23
Methods of treating OX40 mediated recall immune responses Grant 7,807,156 - Croft , et al. October 5, 2	2010-10-05
LIGHT Inhibitors For Asthma, Lung and Airway Inflammation, Respiratory, Interstitial, Pulmonary and Fibrotic Disease Treatment App 20090136427 - Croft; Michael ; et al.	2009-05-28
Methods of treating OX40 mediated recall immune responses and agents useful for identifying same Grant 7,531,170 - Croft , et al. May 12, 2	2009-05-12
Methods of treating OX40 medicated recall immune responses Grant 7,291,331 - Croft , et al. November 6, 2	2007-11-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.